Evidence map›Paper›PMID 39205386›Full record

ArticleClinical pharmacology and therapeutics2025

A Pooled Population Pharmacokinetic Study of Oral and Intravenous Administration of Clavulanic Acid in Neonates and Infants: Targeting Effective Beta-Lactamase Inhibition.

Stef Schouwenburg, Fleur M Keij, Gerdien A Tramper-Stranders, René F Kornelisse, Irwin K M Reiss, Pieter A J G De Cock, Evelyn Dhont, Kevin M Watt, Anouk E Muller, Robert B Flint and 3 more

Abstract read
In one paragraph

Article in Clinical pharmacology and therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Optimization of pediatric dosing regimens for aztreonam and amoxicillin/clavulanate combination therapy against multidrug-resistant bacteria.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Stef Schouwenburg *Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands.ORCID 0000-0003-1835-0749
Fleur M Keij *Division of Neonatology, Department of Neonatal and Pediatric Intensive Care, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.ORCID 0000-0002-1469-1952
Gerdien A Tramper-StrandersDivision of Neonatology, Department of Neonatal and Pediatric Intensive Care, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.ORCID 0000-0002-0228-5375
René F KornelisseDivision of Neonatology, Department of Neonatal and Pediatric Intensive Care, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.
Irwin K M ReissDivision of Neonatology, Department of Neonatal and Pediatric Intensive Care, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.ORCID 0000-0002-9474-6895
Pieter A J G De CockDepartment of Pharmacy, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0001-7634-7471
Evelyn DhontDepartment of Pediatric Intensive Care, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0002-8969-2941
Kevin M WattDuke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0002-5975-5091
Anouk E MullerDepartment of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands.ORCID 0000-0001-5042-6251
Robert B FlintDepartment of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands.ORCID 0000-0002-3658-594X
Birgit C P KochDepartment of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands.ORCID 0000-0002-1202-3643
Karel Allegaert *Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands.ORCID 0000-0001-9921-5105
Tim Preijers *Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands.ORCID 0000-0001-6953-0358

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data published on the oral clavulanic acid pharmacokinetics in the pediatric population is lacking. This research aimed to describe clavulanic acid disposition following oral and intravenous administration and to provide insights into clavulanic acid exposure based on threshold concentrations for (pre-)term neonates and infants. This pooled population pharmacokinetic study combined four datasets for analysis in NONMEM v7.4.3. Clavulanic acid exposure was simulated using the percentage of time above the threshold concentrations (%fT > C

Indexed as

Administration, Intravenousbeta-Lactamase InhibitorsClavulanic AcidAdministration, OralAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial AgentsBiological AvailabilityFemaleHumansInfantInfant, NewbornMaleModels, BiologicalAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial Agentsbeta-Lactamase InhibitorsClavulanic Acid

Identifiers

PMID39205386
PMCPMC11652805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.